These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26169564)

  • 1. A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.
    Ling I; Mihalik B; Etherington LA; Kapus G; Pálvölgyi A; Gigler G; Kertész S; Gaál A; Pallagi K; Kiricsi P; Szabó É; Szénási G; Papp L; Hársing LG; Lévay G; Spedding M; Lambert JJ; Belelli D; Barkóczy J; Volk B; Simig G; Gacsályi I; Antoni FA
    Eur J Pharmacol; 2015 Oct; 764():497-507. PubMed ID: 26169564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of extra-synaptic α5-GABA
    Etherington LA; Mihalik B; Pálvölgyi A; Ling I; Pallagi K; Kertész S; Varga P; Gunn BG; Brown AR; Livesey MR; Monteiro O; Belelli D; Barkóczy J; Spedding M; Gacsályi I; Antoni FA; Lambert JJ
    Neuropharmacology; 2017 Oct; 125():353-364. PubMed ID: 28807671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loop-F of the α-subunit determines the pharmacologic profile of novel competitive inhibitors of GABA
    Mihalik B; Pálvölgyi A; Bogár F; Megyeri K; Ling I; Barkóczy J; Bartha F; Martinek TA; Gacsályi I; Antoni FA
    Eur J Pharmacol; 2017 Mar; 798():129-136. PubMed ID: 28153485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors.
    Ballard TM; Knoflach F; Prinssen E; Borroni E; Vivian JA; Basile J; Gasser R; Moreau JL; Wettstein JG; Buettelmann B; Knust H; Thomas AW; Trube G; Hernandez MC
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):207-23. PubMed ID: 18936916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural pharmacology of the α5-GABA
    Gacsályi I; Móricz K; Gigler G; Wellmann J; Nagy K; Ling I; Barkóczy J; Haller J; Lambert JJ; Szénási G; Spedding M; Antoni FA
    Neuropharmacology; 2017 Oct; 125():30-38. PubMed ID: 28694097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models.
    Rivas FM; Stables JP; Murphree L; Edwankar RV; Edwankar CR; Huang S; Jain HD; Zhou H; Majumder S; Sankar S; Roth BL; Ramerstorfer J; Furtmüller R; Sieghart W; Cook JM
    J Med Chem; 2009 Apr; 52(7):1795-8. PubMed ID: 19275170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.
    Shafie A; Mohammadi-Khanaposhtani M; Asadi M; Rahimi N; Ranjbar PR; Ghasemi JB; Larijani B; Mahdavi M; Shafaroodi H; Dehpour AR
    Mol Divers; 2020 Feb; 24(1):179-189. PubMed ID: 30895449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and pharmacological evaluation of novel 1,2,4-triazol-3-amine derivatives as potential agonists of GABA
    Jahani R; Reza Abtahi S; Nematpour M; Fasihi Dastjerdi H; Chamanara M; Hami Z; Paknejad B
    Bioorg Chem; 2020 Nov; 104():104212. PubMed ID: 32916390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Benzodiazepine Ligand with Improved GABA
    Simeone X; Koniuszewski F; Müllegger M; Smetka A; Steudle F; Puthenkalam R; Ernst M; Scholze P
    Mol Pharmacol; 2021 Jan; 99(1):39-48. PubMed ID: 33268553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes.
    Hammer H; Ebert B; Jensen HS; Jensen AA
    PLoS One; 2015; 10(3):e0120239. PubMed ID: 25798598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition.
    Chambers MS; Atack JR; Broughton HB; Collinson N; Cook S; Dawson GR; Hobbs SC; Marshall G; Maubach KA; Pillai GV; Reeve AJ; MacLeod AM
    J Med Chem; 2003 May; 46(11):2227-40. PubMed ID: 12747794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series.
    Achermann G; Ballard TM; Blasco F; Broutin PE; Büttelmann B; Fischer H; Graf M; Hernandez MC; Hilty P; Knoflach F; Koblet A; Knust H; Kurt A; Martin JR; Masciadri R; Porter RH; Stadler H; Thomas AW; Trube G; Wichmann J
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5746-52. PubMed ID: 19726184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABA
    Poe MM; Methuku KR; Li G; Verma AR; Teske KA; Stafford DC; Arnold LA; Cramer JW; Jones TM; Cerne R; Krambis MJ; Witkin JM; Jambrina E; Rehman S; Ernst M; Cook JM; Schkeryantz JM
    J Med Chem; 2016 Dec; 59(23):10800-10806. PubMed ID: 27933953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating enhanced GABAergic inhibition in Down syndrome: use of GABA α5-selective inverse agonists.
    Martínez-Cué C; Delatour B; Potier MC
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():218-27. PubMed ID: 24412222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides.
    Librowski T; Kubacka M; Meusel M; Scolari S; Müller CE; Gütschow M
    Eur J Pharmacol; 2007 Mar; 559(2-3):138-49. PubMed ID: 17250826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Epileptic Effects of FABP3 Ligand MF1 through the Benzodiazepine Recognition Site of the GABA
    Yabuki Y; Liu J; Kawahata I; Izumi H; Shinoda Y; Koga K; Ueno S; Shioda N; Fukunaga K
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.